Case Challenges in Clinical Use of PCSK9 Inhibitors

Case Challenges in Clinical Use of PCSK9 Inhibitors is organized by RealCME and will be held from Feb 07, 2019 - Feb 07, 2020. 

Target Audience:
This CME activity will target Lipidologists, Cardiologists, Endocrinologists, Primary Care Providers (MDs/DOs), Nurse Practitioners (NPs), Physician Assistants (PAs), other healthcare providers who practice in a primary care setting.

Credits:
0.5 AMA PRA Category 1 Credit(s)™

Objectives:
• Review the latest clinical trial data on PCSK9 inhibitors in reducing cardiovascular events in patients with hypercholesterolemia.
• Discuss the optimal LDL-C goal for patients with hypercholesterolemia at increased risk for cardiovascular events.
• Select appropriate patients for nonstatin lipid-lowering therapy.
• Recognize common reasons for PCSK9 inhibitor denial and implement a team-based approach to improve patient access.

Relevant Terms: 
PCSK9 inhibitors; non-statin therapy; LDL-C; lipid-lowering therapy; hypercholesterolemia